Respire Diagnostics is a spin-out from Imperial College London. We were recruited by the UK Department for International Trade to set up our HQ in London, and secured funding from the UK Research and Innovation.
Using exhaled breath, we identify bio-markers that correlates to respiratory diseases for patient identification and condition monitoring.
We have a vision that measurements of the concentration of biomarkers in exhaled breath will be the next generation of medical diagnostic tool. It is a non-invasive, instantaneous and inexpensive way of quantifying a patients' condition which fulfils the unmet need in a growing market.
Our company has two on-going clinical trials with Imperial College London and Royal Brompton & Harefield Hospital (National Heart and Lung Institute)